Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

NCT02135666 ·Status: WITHDRAWN ·Phase: PHASE4

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

NCT00875485 ·Status: COMPLETED ·Phase: PHASE4

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

NCT00603252 ·Status: COMPLETED ·Phase: PHASE4

Twinrix Alternative Schedule Study

NCT00216229 ·Status: UNKNOWN ·Phase: PHASE4

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01037114 ·Status: COMPLETED ·Phase: PHASE4

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

NCT00289731 ·Status: COMPLETED ·Phase: PHASE4

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01000324 ·Status: COMPLETED ·Phase: PHASE4

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

NCT00343915 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

NCT00291876 ·Status: COMPLETED ·Phase: PHASE4

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

NCT02052661 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

NCT00289757 ·Status: COMPLETED ·Phase: PHASE4

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

NCT01126853 ·Status: WITHDRAWN ·Phase: PHASE4

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

NCT00696917 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

NCT00696891 ·Status: COMPLETED ·Phase: PHASE3

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

NCT02901951 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

NCT00684671 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

NCT00197158 ·Status: COMPLETED ·Phase: PHASE4

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

NCT05561673 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths

NCT00107042 ·Status: COMPLETED ·Phase: PHASE2

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00356564 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults

NCT06989788 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

NCT02153320 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

NCT00697970 ·Status: COMPLETED ·Phase: PHASE3